<DOC>
	<DOCNO>NCT02518204</DOCNO>
	<brief_summary>The purpose study evaluate concurrent validity Brain Performance Test ( BPT ) subtests corresponding conventional in-person neuropsychological assessment ( NP ) .</brief_summary>
	<brief_title>Validity Online Neurocognitive Test Battery , Brain Performance Test ( BPT ) , Normal Healthy Adults</brief_title>
	<detailed_description>This multi-site , randomize , counterbalance , two-period , two-sequence , validation study online , unsupervised Brain Performance Test ( BPT ) . Over course 14 day , participant complete two in-clinic visit complete BPT in-person neuropsychological assessment ( NP ) .</detailed_description>
	<criteria>Native English speaker Capable willing provide inform consent Able use computer mouse without assistance Limited ( &lt; 3 day ) experience Lumosity.com Limited ( &lt; 3 day ) experience cognitive training program ( e.g. , FitBrains , CogMed ) Willing refrain online cognitive training course study No recent ( &lt; 1 year ) experience either computerbased inperson neuropsychological test ( e.g. , WAISIV , WISC , HalsteadReitan Battery , MATRICS , CogState , CNS Vital Signs ) Good general health assess via selfreported online physical questionnaire medical history questionnaire Illiterate unable understand write English sufficiently comprehend study instruction consent form Uncorrected visual impairment ( beyond require qualify California Driver 's License ) may impact ability complete assessment ( selfreport determine clinician ) Uncorrected auditory impairment may impact ability complete assessment ( selfreport determine clinician ) Selfreported clinical diagnosis primary psychiatric neurological disorder ( e.g. , schizophrenia , multiple sclerosis , attention deficit hyperactivity disorder , Parkinson 's disease , epilepsy ) Selfreported history concussion traumatic brain injury , consider clinically significant opinion investigator ( e.g . loss consciousness â‰¤ 30 minute ) Selfreported diagnosis mental retardation pervasive developmental disorder Selfreported diagnosis Mild Cognitive Impairment , Alzheimer 's disease , dementia Selfreported history sustain substance alcohol abuse dependence , consider clinically significant opinion investigator ( e.g . define DSM5 ) Selfreport subject currently take antipsychotic , antidepressant , antianxiety , cognitivelyenhancing medication ( e.g . Ritalin ) , last 72 hour , narcotic pain medication may impact cognitive performance ( e.g . sleep medications/aides cold/allergy medication ) Any significant medical condition could impact cognitive performance result cognitive impairment opinion investigator Score &lt; 28 MMSE Positive urine test recent substance use either test day Breath Alcohol Content 0.01 % great either test day</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>cognitive assessment</keyword>
	<keyword>neuropsychological assessment</keyword>
	<keyword>Brain Performance Test</keyword>
	<keyword>computerized assessment</keyword>
</DOC>